Estupiñán, H. Y., Wang, Q., Berglöf, A., Schaafsma, G. C. P., Shi, Y., Zhou, L., . . . Smith, C. I. E. (2021). BTK gatekeeper residue variation combined with cysteine 481 substitution causes super-resistance to irreversible inhibitors acalabrutinib, ibrutinib and zanubrutinib. Leukemia.
Trích dẫn kiểu ChicagoEstupiñán, H. Yesid, et al. "BTK Gatekeeper Residue Variation Combined With Cysteine 481 Substitution Causes Super-resistance to Irreversible Inhibitors Acalabrutinib, Ibrutinib and Zanubrutinib." Leukemia 2021.
Trích dẫn MLAEstupiñán, H. Yesid, et al. "BTK Gatekeeper Residue Variation Combined With Cysteine 481 Substitution Causes Super-resistance to Irreversible Inhibitors Acalabrutinib, Ibrutinib and Zanubrutinib." Leukemia 2021.